| publications: |
| 1: Stephenson, Iain et al. (2004) Confronting the avian influenza threat: vaccine development for a potential pandemic Lancet Infect Dis 4:499-509 |
| 2: Stephenson, I et al. (2002) Healthcare workers and their attitudes to influenza vaccination Commun Dis Public Health 5:247-52 |
| 3: Stephenson, I et al. (2002) The epidemiology of influenza Occup Med (Lond) 52:241-7 |
| 4: Stephenson, I et al. (2002) Jaundice in primary school pupils Postgrad Med J 78:56, 59 |
| 5: Stephenson, Iain et al. (2008) Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1 N Engl J Med 359:1631-3 |
| 6: Stephenson, Iain et al. (2007) Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study Vaccine 25:4056-63 |
| 7: Pareek, Manish et al. (2007) Clinical evaluation of vaccines for pandemic influenza H5N1 Br J Hosp Med (Lond) 68:80-4 |
| 8: Lu, Xiuhua et al. (2006) Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses Vaccine 24:6588-93 |
| 9: Stephenson, Iain et al. (2006) H5N1 vaccines: how prepared are we for a pandemic? Lancet 368:965-6 |
| 10: Democratis, Jane et al. (2006) Use of neuraminidase inhibitors to combat pandemic influenza J Antimicrob Chemother 58:911-5 |
| 11: Stephenson, Iain et al. (2006) Development of vaccines against influenza H5 Lancet Infect Dis 6:458-60 |
| 12: Stephenson, Iain et al. (2006) Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers J Virol 80:4962-70 |
| 13: Hoelscher, Mary A et al. (2006) Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice Lancet 367:475-81 |
| 14: Stephenson, Iain et al. (2006) Development and evaluation of influenza pandemic vaccines Lancet Infect Dis 6:71-2 |
| 15: Stephenson, Iain et al. (2005) Influenza: current threat from avian influenza Br Med Bull 75:63-80 |
| 16: Crawford, P C et al. (2005) Transmission of equine influenza virus to dogs Science 310:482-5 |
| 17: Stephenson, Iain et al. (2005) Are we ready for pandemic influenza H5N1? Expert Rev Vaccines 4:151-5 |
| 18: Stephenson, Iain et al. (2005) Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy J Infect Dis 191:1210-5 |
| 19: Stephenson, Iain et al. (2003) Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial Lancet 362:1959-66 |
| 20: Stephenson, Iain et al. (2003) Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population Vaccine 21:1687-93 |
| 21: Stockton, Joanne et al. (2002) Human metapneumovirus as a cause of community-acquired respiratory illness Emerg Infect Dis 8:897-901 |